SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

2012/01/31 by Stephen R. Durham, W. Emminger, Waltraud Emminger +14 · 2 citations
Medicine · #Allergic Rhinitis and Sensitization #Ocular Surface and Contact Lens #Sinusitis and nasal conditions

paper · doi:10.1016/j.jaci.2011.12.973

openalex publication_date 2012/01/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• The IgE-facilitated allergen binding (FAB) assay: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

Cited by

• Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations
• Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy